Chromatide and Novasep extend partnership

Published: 30-May-2008

UK company Chromatide and Novasep, of France, have extended their partnership to develop large-scale solid phase peptide and oligonucleotide synthesis technology.


UK company Chromatide and Novasep, of France, have extended their partnership to develop large-scale solid phase peptide and oligonucleotide synthesis technology.

The resulting systems and equipment will meet the growing needs of biotechnology and pharmaceutical industries for more efficient, continuous flow instruments for gram to industrial scale production of high quality products.

The aim is to combine Chromatide's experience in solid phase synthesis of peptide and oligonucleotides, including the production of novel resins and instrumentation, with Novasep's expertise in synthesis and purification services and technologies in the biotechnology and pharmaceutical industries to provide them with efficient solutions to obtain pure peptides and oligonucleotides.

"The extension of our collaboration is illustrative of the success we have achieved to date on developing the synthesis systems that Novasep is launching in 2008," said Dr Don Wellings, Chromatide's cso.

"Peptide manufacturers lack a cost efficient, automated solid phase synthesis technology, fully scalable from gram to ton," added Jean Blehaut, president of Novasep Process Pharma Business Unit. "We believe that these innovative systems combined with our chromatography and membrane technology portfolio will allow us to provide a unique, global process solution for peptides but also for oligonucleotides manufacturers."

You may also like